Atlas Venture Associates IX’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $316K | Hold |
|
|||||
|
2023
Q2 | $408K | Hold |
|
|||||
|
2023
Q1 | $373K | Hold |
|
|||||
|
2022
Q4 | $349K | Hold |
|
|||||
|
2022
Q3 | $560K | Hold |
|
|||||
|
2022
Q2 | $518K | Hold |
|
|||||
|
2022
Q1 | $727K | Hold |
|
|||||
|
2021
Q4 | $1.18M | Hold |
|
|||||
|
2021
Q3 | $1.34M | Hold |
|
|||||
|
2021
Q2 | $1.62M | Sell |
|
|||||
|
2021
Q1 | $89.4M | Sell |
|
|||||
|
2020
Q4 | $87.9M | Hold |
|
|||||
|
2020
Q3 | $32.1M | Hold |
|
|||||
|
2020
Q2 | $34M | Hold |
|
|||||
|
2020
Q1 | $19.8M | Hold |
|
|||||
|
2019
Q4 | $23.7M | Hold |
|
|||||
|
2019
Q3 | $21.6M | Hold |
|
|||||
|
2019
Q2 | $26.4M | Hold |
|
|||||
|
2019
Q1 | $27.6M | Hold |
|
|||||
|
2018
Q4 | $22M | Hold |
|
|||||
|
2018
Q3 | $46.2M | Sell |
|
|||||
|
2018
Q2 | $50.3M | Sell |
|
|||||
|
2018
Q1 | $48.1M | Sell |
|
|||||
|
2017
Q4 | $68.8M | Hold |
|
|||||
|
2017
Q3 | $89M | Sell |
|
|||||
|
2017
Q2 | $59.7M | Hold |
|
|||||
|
2017
Q1 | $52.6M | Sell |
|
|||||
|
2016
Q4 | $58.1M | Buy |
|